UMR CNRS 5558 Laboratoire de Biométrie et Biologie Évolutive

article :
Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, Boissel J-P, Kassai B, Moreau A, Gueyffier F, Cornu C (2012)
Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials, PLoS Med, vol. 9 pp.347-351

Marchant I, Nony P, Cucherat M, Boissel J-P, Thomas SR, Bejan-Angoulvant T, Laugerotte A, Kahoul R, Gueyffier F (2011)
The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies, PLoS ONE, vol. 6(3) pp.1-7

Boissel J-P, Cucherat M, Nonyc P, Chabaud S, Gueyffier F, Wright JM, Lièvre M, Leizorovicz A (2008)
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear, Journal of Clinical Epidemiology, vol. 61(3) pp.301-307

Kassaï B, Cucherat M, Bellon G (2008)
Ciclesonide noninferiority to placebo on growth velocity, Pediatrics, vol. 122 pp.676-677

Amsallem E, Kasparian C, Cucherat M, Chabaud S, Haugh MC, Boissel J-P, Nony P (2007)
Evaluation of two evidence-based knowledge transfer interventions for physicians. A cluster randomized controlled factorial design trial: the CardioDAS study, Fundamental & Clinical Pharmacology, vol. 21 pp.631-641

Kassaï B, Chiron C, Augier S, Cucherat M, Rey E, Gueyffier F, Guerrini R, Vincent J, Dulac O, Pons G (2007)
Severe myoclonic epilepsy in infancy: A systematic review and a meta-analysis of individual patient data, Epilepsia, vol. 48 pp.1-6

Blesius A, Chabaud S, Cucherat M, Mismetti P, Boissel J-P, Nony P (2006)
Compliance-Guided Therapy: A New Insight Into the Potential Role of Clinical Pharmacologists, Clinical Pharmacokinetics, vol. 45 pp.95-104

Dupuis O, Moreau R, Silveira R, Pham MT, Zentner A , Cucherat M, Rudigoz R-C, Redarce T (2006)
A new obstetric forceps for the training of junior doctors: A comparison of the spatial dispersion of forceps blade trajectories between junior and senior obstetricians, American Journal of Obstetrics and Gynecology, vol. 194 pp.1524-1531

Barna A, Baudet M, Cambou J-P, Chatellier G, Cucherat M, Dallongeville J, Durlach V, Giral P, Gueyffier F, Kownator S, Lang T, Léonard D, Pace E, Paillard F, Vallée J-P, Vergès B, Aquino J-P , Aulanier S, Balarac N, Beucler I, Bobrie G, Caporossi L, Dénolle T, D`Ivernois C, Dumarcet N, Erpeldinger S, Farnier M, Ferrières J, Fischer C, Friocourt P, Girerd X, Godin M, Halimi S, Jean T, Lièvre M, Loirat P, Lucas C, Marechaud R, Marre M, Ménard J, Mimran A, Moulin P, Picard S, Poncelet P, Pouchain D, Scarabin P-Y, Seux M-L, Senechal M, Sicard D, Turpin G, Vaisse B, Vallée J (2005)
Methods for evaluation of total cardiovascular risk, Médecine thérapeutique, vol. 11 pp.233-236

Boissel J-P, Cucherat M, Nony P , Dronne MA, Kassaï B, Chabaud S (2005)
Modélisation numérique et simulation : nouvelles applications en pharmacologie, Thérapie, vol. 60 pp.1-15

Boissel J-P, Nony P, Amsallem E, Mercier C, Estève J, Cucherat M (2005)
How to measure non-consistency of medical practices with available evidence in therapeutics: a methodological framework, Fundamental & Clinical Pharmacology, vol. 19 pp.591-596

Kassaï B, Boissel J-P, Cucherat M, Boutitie F, Gueyffier F (2005)
Treatment of high blood pressure and gain in event-free life expectancy, Vascular health and risk management, vol. 1 pp.163-169

Kassaï B, Shah NR, Leizorovicz A, Cucherat M, Gueyffier F, Boissel J-P (2005)
The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests, Journal of Clinical Epidemiology, vol. 58 pp.1042-1051

Dronne MA, Boissel J-P , Grenier E , Gilquin H, Cucherat M, Hommel M, Barbier E, Bricca G (2004)
Mathematical modelling of an ischemic stroke: An integrative approach, Acta Biotheoretica, vol. 52 pp.255-272

Kassaï B, Boissel J-P, Cucherat M, Sonie S, Shah NR , Leizorovicz A (2004)
A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients, Thrombosis and Haemostasis, vol. 91 pp.655-666

Uzzan B, Nicolas P, Cucherat M, Perret GY (2004)
Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis, Cancer Research, vol. 64 pp.2941-2955

Boissel J-P, Gueyffier F, Cucherat M, Bricca G (2003)
Pharmacogenetics and responders to a therapy: Theoretical background and practical problems, Clinical Chemistry and Laboratory Medicine, vol. 41 pp.564-572

Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G , Touboul P (2003)
Amiodarone versus placebo and classic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis, Journal of the American College of Cardiology, vol. 41 pp.255-262

Clanet M, Cucherat M (2003)
Interferons in Relapsing-remitting MS: A systematic Review - Comments on a Meta-analysis, The International MS Journal, vol. 10 pp.134-135

Cucherat M (2003)
Lecture critique : un outil pragmatique, La revue du praticien - médecine générale, vol. 17 pp.752-754

Cucherat M, Leizorovicz A (2003)
La méta-analyse des essais thérapeutiques. Concepts et interprétation des résultats, MT Thérapeutique, vol. 9 pp.73-78

Gueyffier F, Cucherat M (2003)
"Causality and statistical association (2) Mechanical determinism and stochastic model", La Revue du praticien, vol. 53 pp.933-936

Kassaï B, Gueyffier F, Boissel J-P, Boutitie F, Cucherat M (2003)
Absolute benefit number needed to treat and gain in life expectancy: which efficacy indices for measuring the treatment benefit?, Journal of Clinical Epidemiology, vol. 56 pp.977-982

Leizorovicz A, Kassaï B, Becker F, Cucherat M (2003)
The assessment of deep vein thromboses for therapeutic trials, Angiology, vol. 54 pp.19-24

Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY (2003)
Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis - A comprehensive meta-analysis, Archives of Internal Medicine, vol. 163 pp.1514-1522

inbook :
Cucherat M, Bonnefoy E, Tremeau G (2003)
Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction, , vol. 3 pp.752-754